Protection of urinary bladder function by grape suspension

Phytotherapy Research

Volumn 18, Issue 12, 2004, Pages 1013-1018

  Agartan, Canan Aldirmaz ^a   Whitbeck, Catherine ^b,c   Sokol, Rebekah ^d   Chichester, Paul ^b,c   Levin, Robert M ^b,c,e  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c STRATTON VA MEDICAL CENTER   (United States)

^d Albany Academy for Girls   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Bladder; Grape; Obstruction; Reperfusion; Resveratrol

Indexed keywords

ANTHOCYANIN; ANTIOXIDANT; CHOLINE ACETYLTRANSFERASE; FLAVAN DERIVATIVE; FLAVONOL DERIVATIVE; GRAPE EXTRACT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLADDER DYSFUNCTION; CONTROLLED STUDY; CYSTOMETRY; DRUG EFFICACY; ENZYME ACTIVITY; GRAPE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMBRANE STABILIZATION; MICTURITION; NEUROFILAMENT; NONHUMAN; ORGAN WEIGHT; RABBIT; SMOOTH MUSCLE CONTRACTILITY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ISOMETRIC CONTRACTION; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC HYPERPLASIA; RABBITS; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS; VITIS;

EID: 14044256422     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1620     Document Type: Article

References (24)

1. Aldini G, Carini M, Piccoli A, Rossoni G, Facino RM. 2003. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidence for cardio-protection. Life Sci 73: 2883-2898.
2. Barry MJ, Meigs JB. 2000. The natural history of benign prostatic hyperplasia. In Prostatic Diseases, Lepor H (ed.). W.B. Saunders: Philadelphia, 106-115.
3. Cellarnotes, World comparison of wine production/export, consumption; grape production/consumption; http:// www.cellarnotes.net/world_comparison.htm.
4. Das DK, Sato M, Ray PS, et al. 1999. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res 25: 115-120.
5. Folts JD. 2002. Potential health benefits from the flavonoids in grape products on vascular disease. Adv Exp Med Biol 505: 95-111.
6. Freedman JE, Parker C III, Li L, et al. 2001. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103: 2792-2798.
7. Girman CJ, Guess HA. 2000. Epidemiology of benign prostatic hyperplasia. In Prostatic disease, Lepor H (ed.). W.B. Saunders: Philadelphia, 116-126.
8. Greenland JE, Hvistendahl JJ, Andersen H, et al. 2000. The effect of bladder outlet obstruction on tissue oxygen tension and blood flow in the pig bladder. BJU Int 85: 1109-1114.
9. Hakenberg O, Linne C, Manseck A, Wirth MP. 2000. Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement. Neurourol Urodyn 19: 585-593.
10. Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ. 2000. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative metaanalysis. Am J Med 109: 654-664.
11. Lamuella-Raventos RM, de la Torre-Boronat MC. 1999. Beneficial effects of white wines. Drugs Exp Clin Res 25: 121-124.
12. Levin RM. 2001. Bladder function and dysfunction: biochemical and molecular genetic basis. Drugs of Today 37: 33-37.
13. Levin RM, Chichester P, Hass MA, Gosling JA, Buttyan R. 2002b. Obstructive bladder dysfunction: Morphological, biochemical, and molecular changes. Eur Urol Suppl 1: 14-20.
14. Levin RM, Das AK. 2000. A scientific basis for therapeutic effects of Pygeum africanum and Serenoa repens. Urol Res 28: 201-209.
15. Levin RM, Haugaard N, O'Connor L, et al. 2000. Obstructive response of human bladder to BPH vs rabbit bladder response to partial outlet obstruction: A direct comparison. Neurourol Urodyn 19: 609-629.
16. Levin RM, Kawashima Y, Leggett RE, Whitbeck C, Horan P, Mizutani K. 2002. Effect of oral Kohki tea on bladder dysfunction induced by severe partial outlet obstruction. J Urol 167: 2260-2266.
17. Levin RM, Riffaud J-P, Bellamy F, et al. 1996. Effects of Tadedan pretreatment on bladder physiology and biochemistry following partial outlet obstruction. J Urol 156: 2084-2088.
18. Manier C, Carte SS, Romano G, Trucchi A, Valent, Tubaro A. 1998. The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol 159: 761-765.
19. O'Leary MP. 2003. Lower urinary tract symptoms/benign prostatic hyperplasia: maintaining symptom control and reducing complications. Urology 62 (Suppl 1): 15-23.
20. Oishi K, Barryu MJ, Farah R, et al. 1998. Epidemiology and natural history of benign prostatic hyperplasia. In Proceedings of the 4th International Consultation on BPH, Denis L, Griffiths K, Khoury S, et al. (eds). Health Publication Ltd: London 23-26.
21. Schulman CC. 2003. Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment. Urology 62 (Suppl 1): 24-33.
22. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD. 1999. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100: 1050-1055.
23. van Venrooij GE, van Melick HH, Boon TA. 2003. Comparison of outcomes of transurethral prostate resection in urodynamically obstructed versus selected urodynamically unobstructed or equivocal men. Urology 62: 672-676.
24. Wein AJ, Longhurst PA, Levin RM. 1994. Pharmacologie treatment of voiding dysfunction. In Urodynamics, Principles, Practice, and Application, Mundy AR, Stephenson TP, Wein AJ (eds). Churchill Livingstone: New York, 4370.